Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
about
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunctionBrain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in HumansTreatment of prediabetesTherapeutic Use of Metformin in Prediabetes and Diabetes PreventionType 2 diabetes and cognitive impairment: linking mechanismsMetabolism and breast cancer risk: frontiers in research and practiceInterventions to preserve beta-cell function in the management and prevention of type 2 diabetesLink between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatmentA low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or β-cell mass in NZO mice.HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.Association of an intensive lifestyle intervention with remission of type 2 diabetes.Exercise and diabetes: relevance and causes for response variabilityTCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention programAnti-Diabetic Effect of Portulaca oleracea L. Polysaccharideandits Mechanism in Diabetic RatsExercise training plus metformin, but not exercise training alone, decreases insulin production and increases insulin clearance in adults with prediabetes.Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.The prevention of type 2 diabetes.Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention ProgramEffect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life spanLifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program ParticipantsInsulin resistance in non-obese subjects is associated with activation of the JNK pathway and impaired insulin signaling in skeletal muscle.Physical activity, sedentary behaviors, and estimated insulin sensitivity and secretion in pregnant and non-pregnant women.The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial InfarctInsulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Studyβ-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones).Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic controlPlasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normalPre-gravid physical activity and reduced risk of glucose intolerance in pregnancy: the role of insulin sensitivity.Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.Glucose intolerance after a recent history of gestational diabetes.Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI: a comparative study.Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.Diabetes, related conditions, and dementia.Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention ProgramFactors associated with beta-cell dysfunction in type 2 diabetes: the BETADECLINE study.The Belgian Diabetes in Pregnancy Study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design.
P2860
Q24632414-CAC71187-6C2C-4201-85B0-F0B78A64F18EQ26739671-6D32D911-ABE7-42F6-962E-8E75B0435A30Q26783350-BA40148F-0E96-4049-AFAA-C45F08012CF3Q26822066-67378D11-9DEE-4110-B0A0-6073D605D2B4Q26822993-5C33077F-6A6B-48CF-81EA-DC50642D3A6DQ26823745-F76215CE-5D36-4FFA-BC81-431715D02E64Q26830871-262A8B63-8FD8-43C1-BEEE-A47601AA2027Q26860246-0755328A-0ACA-42B8-82F2-F15C4AD92483Q27310129-3D9BCEDF-F53E-4FBD-8926-30C0F1BEBE1FQ27335063-F3BD75E2-EC0B-4238-99BC-80C00F9E9E97Q27347992-4AC36DE1-2C82-47FE-A7BA-9574C072B62DQ28081508-43CD3999-3CF6-432C-8CF1-FFD3FB10F318Q28742128-02CE72C9-AD51-42A6-897F-D15211EDCD7CQ28828825-C3378BF6-7E7F-49FD-88D0-4B81C4D50B76Q30252438-8C250980-0FD9-44A9-B9D9-4EDDF47EE5CDQ30392979-1DB15B03-F33A-4B69-8264-54D15C0509CAQ30484253-E23787DA-B09D-4401-937E-F353DE970259Q30524978-9A6E5E71-B27E-4871-BB5B-94C7B66EEE72Q30533186-5DFA70D7-1A0E-4BF7-96FB-B936E16C2EF9Q30572405-470F0705-D048-4BB0-80C4-9174CF47697DQ30708887-AAF36197-68BB-4FD0-AB49-16DA664B1911Q31011189-3FCFAF41-36FF-4A38-BFC2-E09D17C104F3Q31018690-7D1EC42F-C658-498A-A2E5-E04E0BA4B97EQ31033137-55A3D979-09D6-4331-8DD1-7764577BDDC4Q33556896-88BDD306-66F6-4884-9F01-0D0F48757664Q33570085-5DF36C0D-6BC1-4221-B290-C1FF78C7C8CDQ33610569-D283D05B-955E-422F-A310-5E095CA2AAF1Q33610661-7ECD4BDF-2726-4574-9099-98713B5C2019Q33881452-3330ADB0-5356-43B1-AFDA-222FAC1C1CD1Q33884449-B7B2DE2D-E44B-4E7C-BDB3-911B7DB1C76AQ33884471-7AE5FBB1-FFF8-4876-92F9-801BBDCA25E8Q33960260-EE6D6436-5B5F-4442-9243-D6DA951A8E24Q34054063-04BB5576-0212-4BA3-B211-C6D7FD65ADF3Q34080165-198A24ED-F501-4AC1-AF6E-103D6B52EB46Q34099229-A214892D-F23C-40AE-A2FF-9811A2A3E9A3Q34294192-0543AE28-0AFC-4F44-A708-4B01B8B32C0EQ34361375-88A9385A-D2A7-4C1D-B159-AF446221A5DEQ34404405-0920343E-4E57-4059-9352-B257B5F99555Q34407830-C1949413-0577-46B9-BF4F-64202F1053EFQ34487118-C7FB22A0-0C79-4C57-BB72-E78DDE5DF04D
P2860
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Role of insulin secretion and ...... le intervention and metformin.
@ast
Role of insulin secretion and ...... le intervention and metformin.
@en
Role of insulin secretion and ...... le intervention and metformin.
@nl
type
label
Role of insulin secretion and ...... le intervention and metformin.
@ast
Role of insulin secretion and ...... le intervention and metformin.
@en
Role of insulin secretion and ...... le intervention and metformin.
@nl
prefLabel
Role of insulin secretion and ...... le intervention and metformin.
@ast
Role of insulin secretion and ...... le intervention and metformin.
@en
Role of insulin secretion and ...... le intervention and metformin.
@nl
P2093
P2860
P50
P921
P1433
P1476
Role of insulin secretion and ...... le intervention and metformin.
@en
P2093
Christopher Saudek
Harry Shamoon
Marinella Temprosa
Mary Beth Murphy
Reuben Andres
Richard Arakaki
Sarah E Fowler
Sharon L Edelstein
Steven E Kahn
Steven M Haffner
P2860
P304
P356
10.2337/DIABETES.54.8.2404
P407
P577
2005-08-01T00:00:00Z